Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Inflammatory mediators and immune cell infiltration describes a complex biological process involving the release of signaling molecules and the subsequent migration of leukocytes into tissues. This process is mediated by a wide variety of molecules, including cytokines, chemokines, and lipid mediators like prostaglandins [1]. Immune cell infiltration is facilitated by the upregulation of adhesion molecules on the vascular endothelium, allowing cells like neutrophils and macrophages to exit the bloodstream [2]. While this mechanism is vital for responding to infection and injury, its dysregulation is a primary driver of chronic inflammatory diseases, such as rheumatoid arthritis and psoriasis [3]. In oncology, the infiltration of specific immune subsets can either promote or inhibit tumor growth, making it a key focus of cancer immunotherapy [4]. Therapeutic interventions often target specific components of this process, such as TNF-alpha inhibitors or integrin blockers, to reduce pathological inflammation [5]. Because it encompasses hundreds of distinct molecular interactions, it is classified as a physiological pathway or therapeutic area rather than a single druggable target [6]. Monitoring this process often involves measuring systemic biomarkers like C-reactive protein or assessing tissue biopsies for cellular density [1]. Sources: [1] StatPearls: Inflammation (https://www.ncbi.nlm.nih.gov/books/NBK493173/); [2] Nature Reviews Immunology: Leukocyte trafficking (https://www.nature.com/articles/nri.2016.10); [3] NIH: Chronic Inflammation (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7147653/); [4] PubMed: Immune infiltration in cancer (https://pubmed.ncbi.nlm.nih.gov/28930642/); [5] Journal of Clinical Investigation: Targeting cytokines (https://www.jci.org/articles/view/124611); [6] Pharmacology & Therapeutics: Drug targets in inflammation (https://doi.org/10.1016/j.pharmthera.2020.107502).
Modulation of pro-inflammatory signaling, neutralization of specific cytokines, inhibition of lipid mediator synthesis, or blockade of leukocyte adhesion and trafficking molecules.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Inflammatory mediators and immune cell infiltration.